Researchers say levels of microRNA in the blood may be a reliable new biomarker for diagnosing mild cognitive impairment and other forms of dementia.
Recent studies have linked air pollution to increased risks for Alzheimer's disease and other health problems. A new study reports a reduction of atmospheric fine particulates and better air quality can reduce the risk of Alzheimer's and other dementias.
A new study reveals an association between high blood pressure in a person's thirties and forties to smaller brain size and an increased risk of developing dementia later in life.
Despite previous claims, new research finds there is no link between menopausal women taking hormone replacement therapy (HRT) and an increased risk of developing dementia.
Depression experienced during early adulthood increases the risk of developing cognitive impairment and dementia later in life, a new study reports.
Feeling content in life slows cognitive decline in older adults, a new study reports. Researchers say the odds of older adults developing cognitive impairment and dementia were reduced in those who reported better psychological well-being.
A new blood test that uses atomic force microscopy technology appears to be effective as an Alzheimer's diagnostic test.
A newly developed two-minute EEG test effectively picks up on early memory impairments associated with Alzheimer's disease.
Greater radiodensity of perivascular adipose tissue in women during midlife was associated with decreased working memory performance later in life.
A new algorithm uses neuroimaging data of amyloid levels in the brain and takes into account a person's age to determine when a person with genetic Alzheimer's risk factors, and with no signs of cognitive decline, will develop the disease.
A newly identified gene therapy pathway has the potential to protect us against dementia and cancer, researchers report.
Researchers identified 33 metabolic compounds in blood samples that differed between those with dementia and cognitively healthy older adults. 7 of the metabolites were elevated in dementia patients, while 26 were at lower levels compared to samples of those without dementia. Elevating levels of those metabolites could have a neuroprotective effect against dementia.
